Literature DB >> 11704385

Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive.

J P Greenwood1, E M Scott, J B Stoker, D A Mary.   

Abstract

OBJECTIVES: This study was designed to examine whether the occurrence of left ventricular hypertrophy (LVH) in moderate to severe essential hypertension (EHT) was associated with alteration in peripheral sympathetic drive.
BACKGROUND: In hypertension, LVH is an independent predictor of increased morbidity and mortality. The reported mechanisms leading to LVH remain unclear but include hemodynamic and humoral factors. The sympathetic nervous system may be important, particularly as catecholamines have been shown to have trophic properties. We tested the hypothesis that sympathetic activity measured using microneurography could be different in patients with hypertension depending on the presence of LVH.
METHODS: We examined 28 subjects with moderate to severe EHT (stages 2 to 3; Joint National Committee [JNC]-VI classification). Fourteen had echocardiographic evidence of LVH (EHT + LVH), while the other 14 subjects (EHT) did not. Subjects were matched in terms of age, body mass index and levels of arterial blood pressure. Peripheral muscle sympathetic nerve activity was measured from both multiunit bursts (MSNA) and single unit (s-MSNA) vasoconstrictor impulses via the peroneal nerve.
RESULTS: The mean frequency of s-MSNA and MSNA was greater in the EHT + LVH group than it was in the EHT group (mean +/- SEM; 75.9 +/- 6.9 impulses/100 beats vs. 52.1 +/- 2.9 impulses/100 beats, p < 0.001 and 64.2 +/- 5.7 bursts/100 beats vs. 48.9 +/- 2.8 bursts/100 beats, p < 0.05).
CONCLUSIONS: These results indicate that, in subjects with moderate to severe hypertension, the presence of LVH is associated with higher sympathetic discharge, evidenced by an increase in unitary firing frequency and also by fiber recruitment.

Entities:  

Mesh:

Year:  2001        PMID: 11704385     DOI: 10.1016/s0735-1097(01)01600-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

Review 1.  Regression of left ventricular hypertrophy is a key goal of hypertension management.

Authors:  Rubin Zhang; Judy Crump; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 2.  Resistant Hypertension and Renal Nerve Denervation.

Authors:  Matthew G Denker; Debbie L Cohen
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

Review 3.  Mechanisms and Subclinical Consequences of Aortic Stiffness.

Authors:  Gary L Pierce
Journal:  Hypertension       Date:  2017-09-05       Impact factor: 10.190

Review 4.  Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.

Authors:  Gino Seravalle; Giuseppe Mancia; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-05-01

5.  Myocardial strain indices and coronary flow reserve are only mildly affected in healthy hypertensive patients.

Authors:  Dimitrios Evangelou; Aris Bechlioulis; Georgios Tzeltzes; Lampros Lakkas; Ioanna Theodorou; Rigas Kalaitzidis; Evangelia Dounousi; Lampros K Michalis; Katerina K Naka
Journal:  Int J Cardiovasc Imaging       Date:  2020-07-30       Impact factor: 2.357

Review 6.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

7.  Essential Role of Ovarian Hormones in Susceptibility to the Consequences of Witnessing Social Defeat in Female Rats.

Authors:  Julie E Finnell; Brandon L Muniz; Akhila R Padi; Calliandra M Lombard; Casey M Moffitt; Christopher S Wood; L Britt Wilson; Lawrence P Reagan; Marlene A Wilson; Susan K Wood
Journal:  Biol Psychiatry       Date:  2018-01-31       Impact factor: 13.382

Review 8.  Cardiac target organ damage in hypertension: insights from epidemiology.

Authors:  Patrick R Lawler; Pranoti Hiremath; Susan Cheng
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 9.  Catheter-based Renal Artery Denervation for Resistant Hypertension: Promise Unfulfilled or Unsettled?

Authors:  Matthew G Denker; Debbie L Cohen; Raymond R Townsend
Journal:  Curr Atheroscler Rep       Date:  2015-10       Impact factor: 5.113

10.  Deficiency of iNOS Does Not Prevent Isoproterenol-induced Cardiac Hypertrophy in Mice.

Authors:  Hye-Na Cha; Geu-Ru Hong; Yong-Woon Kim; Jong-Yeon Kim; Jin-Myoung Dan; So-Young Park
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.